Resistance develops primarily through genetic mutations in the viral genome. These mutations can arise spontaneously or due to selective pressure exerted by the use of antiviral drugs. The frequent and improper use of these drugs accelerates the development of resistant strains. Combination therapy, involving multiple drugs, is often used to reduce the likelihood of resistance development.
